<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00315510</url>
  </required_header>
  <id_info>
    <org_study_id>QPhT05_131005-Rosuvastatine</org_study_id>
    <nct_id>NCT00315510</nct_id>
  </id_info>
  <brief_title>Rosuvastatin and Ischemia Reperfusion</brief_title>
  <official_title>Does Rosuvastatin Reduce Ischemia/Reperfusion Injury in Humans In-Vivo? A Randomized Double Blind Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <brief_summary>
    <textblock>
      Statins, including rosuvastatin, are drugs that lower plasma cholesterol and prevent
      atherosclerotic disease. Recent preclinical evidence suggests that statins also increase
      tissue tolerance to ischemia-reperfusion injury.

      This is a randomized, double blind, parallel designed study comparing the effect of 1 week
      treatment with rosuvastatin (20 mg, once a day) with placebo on forearm ischemia-reperfusion
      injury in healthy male volunteers. Forearm ischemia-reperfusion injury is quantified with
      Tc-99m-annexin A5 scintigraphy of the hands after a standardized ischemic exercise test. For
      this purpose, Tc-99m-rh-annexin A5 (400 MBq; &lt; 5 mSv) is injected intravenously upon
      reperfusion, followed by scintigraphy of both hands with a gamma camera at 1 and 4 hours
      after injection. Annexin A5 targeting is calculated as the percentage difference in activity
      (counts/pixel) between the thenar muscles of both hands.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">August 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>annexin A5 targeting to ischemically exercised hand</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasma lipid levels</measure>
  </secondary_outcome>
  <enrollment>20</enrollment>
  <condition>Ischemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rosuvastatin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers (18-50 years of age)

        Exclusion Criteria:

          -  Hypercholesterolemia

          -  Hypertension
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerard A. Rongen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Pharmacology-Toxicology; Radboud University Medical Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research Centre Nijmegen; Radboud University Nijmegen Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6500 HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Rongen GA, Oyen WJ, Ramakers BP, Riksen NP, Boerman OC, Steinmetz N, Smits P. Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation. 2005 Jan 18;111(2):173-8. Epub 2004 Dec 27.</citation>
    <PMID>15623546</PMID>
  </reference>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2006</study_first_submitted>
  <study_first_submitted_qc>April 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2006</study_first_posted>
  <last_update_submitted>September 22, 2008</last_update_submitted>
  <last_update_submitted_qc>September 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2008</last_update_posted>
  <keyword>Ischemia-reperfusion</keyword>
  <keyword>Annexin A5</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rosuvastatin Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

